The Leukemia Research Foundation is proud to announce the funding of 13 blood cancer research grants for the 2020-2021 funding year.
NORTHFIELD, Ill., July 31, 2020 -- The Leukemia Research Foundation is proud to announce the funding of 13 blood cancer research grants for the 2020-2021 funding year. One-year grants of up to $100,000 each are awarded to New Investigators through the Foundation’s Hollis Brownstein Research Grants Program.
Congratulations to the following grantees who will begin their research projects this summer.
Jeevisha Bajaj, Ph.D. - Rochester University, New York
Role of SLC6A6 in Aggressive Myeloid Leukemia
Triona Ni Chonghaile, Ph.D., BSc - Royal College of Surgeons, Ireland
Identifying and Epigenetically Inducing BCL-2 Dependence in Multiple Myeloma
Sergi Cuartero, Ph.D. - Josep Carreras Leukaemia Research Institute, Spain
Identifying Novel Transcriptional Vulnerabilities in MDS with Cohesin Mutations
Heiko Konig, M.D., Ph.D. - Indiana University
A Novel Approach to Target Drug Resistant Acute Myeloid Leukemia Cells
Bridget Marcellino, M.D., Ph.D. - Icahn School of Medicine at Mt. Sinai, New York
Enhancing Natural Killer Cell Recognition of Leukemic Cells
Fabiana Perna, M.D., Ph.D. - Indiana University
Interrogation of the Leukemia Cell Surfaceome for Immune-Targeting
Yana Pikman, M.D. - Dana-Farber Cancer Institute, Massachusetts
Novel Combination Strategy for Targeting One-Carbon Folate Metabolism for T-Cell Acute Lymphoblastic Leukemia Therapy
Giovanni Roti, M.D., Ph.D. - University of Parma, Italy
Targeting NOTCH1 Trafficking Vulnerabilities in T-Cell Acute Lymphoblastic Leukemia
Simone Sidoli, Ph.D. - Albert Einstein College of Medicine, New York
Accessible Heterochromatin as New Target Against Acute Myeloid Leukemia Development
George Souroullas, Ph.D. - Washington University, Missouri
Understanding the Oncogenic Mechanisms and Chromatin Interactions of EZH2 Mutations in Lymphoma
Liling Wan, Ph.D. - University of Pennsylvania Perelman School of Medicine
Targeting the Chromatin Reader Protein ENL in Acute Leukemias
Siao-Yi Wang, M.D., Ph.D. - Loyola University Cardinal Bernardin Cancer Center, Illinois
Engineering CD19-Specific Chimeric Antigen Receptor T-Cells Without Inducing Cell Division or Differentiation
Yibin Yang, Ph.D. - Research Institute of Fox Chase Cancer Center, Pennsylvania
Investigating and Therapeutic Targeting of the IL1R1-Myd88 Pathway in Anaplastic Large Cell Lymphoma
“This year the Leukemia Research Foundation received a record number of letters of intent (LOI) from blood cancer researchers around the world,” said Executive Director Kevin Radelet.
“Providing grants to New Investigators is critically important. New Investigators are a key niche of innovative scientists who are beginning to establish their own laboratories and are no longer under the tutelage of a senior scientist mentor. The funding enables New Investigators to act on their ideas, and try new procedures and experiments that will lead to significant breakthroughs,” Radelet said.
The Leukemia Research Foundation Medical Advisory Board (MAB), led by Chairperson Patrick J. Stiff, M.D., Division Director, Hematology/Oncology at Loyola Medicine in Maywood, Ill., reviews the LOIs, then recommends that the Foundation invite the most promising project applicants to submit full grant proposals. Dozens of full proposals are then evaluated using the same methodology employed by the National Institutes of Health (NIH). Final recommendations are submitted to the Leukemia Research Foundation for funding.
The Leukemia Research Foundation has funded more than 500 research projects on five continents since 1946, raising for than $80 million to fund research and provide patient support. This year’s group of grantees began receiving funds July 1. More information on the Hollis Brownstein Research Grants program can be found at https://allbloodcancers.org/
About The Leukemia Research Foundation (LRF)
The Leukemia Research Foundation, a CharityNavigator.org 4-Star Charity headquartered in Northfield, Ill., is dedicated to conquering all blood cancers by funding research into their causes and cures, and enriching the quality of life of those touched by these diseases. Since 1946, thousands of volunteers and 21 current volunteer chapters have helped the Foundation raise more than $80 million to help fund research specifically targeting aspiring, eager, and innovative scientists and physicians around the world to find a cure for all blood cancers.
Leukemia Research Foundation information is available at www.allbloodcancers.org, or by calling 847-424-0600.
